SENTAN Pharma Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
SENTAN Pharma General Information
Description
Operator of a biotechnology company intended to conduct research and development of nanoparticle formulations for cardiovascular agents. The company's services include contributing to the creation of innovative pharmaceuticals and medical devices, as well as health food using nanotechnology, enabling academic researchers to get outputs to the industry.
Contact Information
Website
www.sentan.co.jpCorporate Office
- 9th Floor, 2-1 Shimokawabata-machi
- Hakataza/West Bank Redevelopment Building, Hakata-ku
- Fukuoka, 812-0027
- Japan
Corporate Office
- 9th Floor, 2-1 Shimokawabata-machi
- Hakataza/West Bank Redevelopment Building, Hakata-ku
- Fukuoka, 812-0027
- Japan
SENTAN Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 04-Dec-2025 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 01-Feb-2024 | Completed | Generating Revenue | |||
| 2. Seed Round | 10-Dec-2020 | $1.73M | $1.81M | Completed | Generating Revenue | |
| 1. Corporate | 01-Feb-2007 | $83K | $83K | Completed | Startup |
SENTAN Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SENTAN Pharma Patents
SENTAN Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026048769-A1 | Excrement odor suppression composition, excrement odor suppression feed, and excrement odor suppression method | Pending | 28-Aug-2024 | ||
| WO-2025254014-A1 | Preparation and kit preparation | Pending | 03-Jun-2024 | ||
| WO-2025243901-A1 | Injection preparation | Pending | 21-May-2024 | ||
| JP-2023122702-A | Injection and use of particle for producing injection | Pending | 24-Feb-2022 | ||
| EP-4470531-A1 | Pharmaceutical composition for treating retinitis pigmentosa | Pending | 28-Jan-2022 | A61K9/5153 |
SENTAN Pharma Signals
SENTAN Pharma Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nippon Soda | Holding Company | Minority | ||
| QB Capital | Venture Capital | Minority | ||
| Kyushu University | University | Minority |
SENTAN Pharma FAQs
-
When was SENTAN Pharma founded?
SENTAN Pharma was founded in 2007.
-
Where is SENTAN Pharma headquartered?
SENTAN Pharma is headquartered in Fukuoka, Japan.
-
What is the size of SENTAN Pharma?
SENTAN Pharma has 20 total employees.
-
What industry is SENTAN Pharma in?
SENTAN Pharma’s primary industry is Drug Discovery.
-
Is SENTAN Pharma a private or public company?
SENTAN Pharma is a Private company.
-
What is SENTAN Pharma’s current revenue?
The current revenue for SENTAN Pharma is .
-
How much funding has SENTAN Pharma raised over time?
SENTAN Pharma has raised $1.81M.
-
Who are SENTAN Pharma’s investors?
Nippon Soda, QB Capital, and Kyushu University have invested in SENTAN Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process